CHICAGO, April 21, 2025 (GLOBE NEWSWIRE) -- FreightCar America, Inc. (NASDAQ: RAIL), a diversified manufacturer of railroad freight cars, today announced that it will release its first quarter 2025 financial results on Monday, May 5, 2025, after the market close and host a teleconference to discuss its first quarter 2025 results on the following day. Teleconference details are as follows: May 6, 202511:00 a.m. Eastern Daylight TimePhone: 1-877-407-0789 or 1-201-689-8562Webcast access at: www.freightcarameri ...

Core Viewpoint - Postal Realty Trust, Inc. will report its financial results for the period ended March 31, 2025, on April 30, 2025, after market close [1] Group 1: Financial Reporting - The financial results will be discussed in a webcast and conference call on May 1, 2025, at 9:00 A.M. Eastern Time [2] - A telephonic replay of the call will be available from May 1, 2025, at 1:00 P.M. Eastern Time until May 15, 2025, at 11:59 P.M. Eastern Time [3] Group 2: Company Overview - Postal Realty Trust, Inc. is an internally managed real estate investment trust that owns and manages over 2,100 properties leased primarily to the United States Postal Service [4]

Core Points - First Financial Northwest, Inc. has declared an initial liquidating distribution of $22.00 per share, totaling approximately $203 million, which represents about 95% of the expected proceeds to be distributed [1] - The initial distribution will be payable on April 30, 2025, to shareholders of record as of April 23, 2025 [1] - The company has closed its stock transfer books and filed a Form 25 with the SEC for delisting its common stock from the Nasdaq Capital Market [1] - A final cash distribution to shareholders is planned after the company completes its wind-down and settles its debts, with estimated total distributions ranging from $23.06 to $23.34 per share [2] Company Overview - First Financial Northwest, Inc. is the former parent company of First Financial Northwest Bank, a commercial bank based in Renton, Washington [3]

RENTON, Wash., April 21, 2025 (GLOBE NEWSWIRE) -- First Financial Northwest, Inc. (NASDAQ GS: FFNW) (the “Company”) today announced that its Board of Directors has declared an initial liquidating distribution pursuant to its previously announced Plan of Dissolution in the amount of $22.00 per share, or approximately $203 million, representing approximately 95% of the anticipated proceeds to ultimately be distributed. The initial liquidating distribution will be payable on April 30, 2025, to shareholders of ...

Core Viewpoint - Galapagos NV is undergoing a planned separation into two independent entities, with Mr. Henry Gosebruch appointed as the founding CEO of the new subsidiary, SpinCo, which will focus on innovative medicines and is initially funded with approximately €2.45 billion in cash and cash equivalents [2][3]. Group 1: Leadership Changes - Dr. Paul Stoffels, the current CEO and Chair of the Board of Directors at Galapagos, plans to retire as CEO within the next 12 months but will remain as Chair, ensuring leadership continuity [1][3]. - The Board of Directors will search for a successor CEO for Galapagos, who will lead the company into its next phase of growth and innovation as a focused cell therapy company [3][4]. Group 2: SpinCo's Focus and Strategy - SpinCo will concentrate on building a pipeline of innovative medicines with demonstrated proof-of-concept, aiming to elevate the standard of care for patients through transformative transactions [2][3]. - The new entity will leverage a strong balance sheet and pursue opportunities that create significant value for shareholders [3][5]. Group 3: Background of Mr. Henry Gosebruch - Mr. Gosebruch has extensive experience in M&A, business development, and venture capital, previously serving as President and CEO at Neumora and Executive Vice President at AbbVie [6][7]. - At AbbVie, he was instrumental in completing over 100 business development transactions, including the acquisition of Allergan [7][8]. - His background includes over 20 years at J.P. Morgan, where he co-headed the North American M&A Group and worked on transactions exceeding $375 billion [8]. Group 4: Galapagos' Strategic Direction - Galapagos aims to transform into an R&D-driven biotech company with a focus on oncology, utilizing a decentralized manufacturing platform for cell therapies [4][9]. - The company is advancing its pipeline of potentially best-in-class assets, with ongoing Phase 2 clinical studies targeting aggressive hematological malignancies and solid tumors [4].

Core Viewpoint - LifeStance Health Group, Inc. is set to release its first quarter 2025 earnings on May 7, 2025, before market opening, highlighting its position as a major player in outpatient mental health care [1]. Group 1: Earnings Release Information - LifeStance will host a live earnings conference call on May 7, 2025, at 8:30 a.m. Eastern Time to discuss the first quarter results [2]. - Participants can join the call by dialing specific domestic and international numbers and using a conference ID [2]. - A real-time audio webcast will be available on the LifeStance Investor Relations website, with related materials posted prior to the call [3]. Group 2: Company Overview - Founded in 2017, LifeStance is one of the largest providers of virtual and in-person outpatient mental health care in the U.S. [4]. - The company employs approximately 7,400 mental health professionals and operates over 550 centers across 33 states [4]. - LifeStance aims to improve access to affordable and personalized mental health care, helping individuals lead healthier lives [4].

Core Viewpoint - Zions Bancorporation reported a strong financial performance in Q1 2025, with net earnings of $169 million, reflecting an 18% increase from the previous year, driven by improved net interest margins and adjusted pre-provision net revenue [1][2]. Financial Performance - Net earnings applicable to common shareholders for Q1 2025 were $169 million, or $1.13 per diluted common share, compared to $143 million, or $0.96 per diluted common share in Q1 2024, and $200 million, or $1.34 per diluted common share in Q4 2024 [1]. - The net interest margin increased by 16 basis points, and adjusted pre-provision net revenue rose by 10% [2]. - A tax law change in Utah resulted in a charge of $0.11 per share to income tax expense, but is expected to accrete back into income over time [2]. Strategic Developments - The acquisition of four branches in California's Coachella Valley added approximately $630 million in deposits and $420 million in loans [2]. - The company aims to enhance service to new customers through its affiliate, California Bank & Trust [2]. Credit Quality - Credit quality remained stable, with nonperforming assets at 0.51% of loans and leases and annualized net charge-offs at 0.11% [2]. - The company expressed confidence in its credit culture and reserves to manage potential economic turbulence [2]. Company Overview - Zions Bancorporation reported annual net revenue of $3.1 billion in 2024 and total assets of approximately $89 billion as of December 31, 2024 [4]. - The company operates under local management teams in 11 western states and is recognized for its customer service in small- and middle-market banking [4].

Group 1 - AEON Biopharma has appointed Rob Bancroft as President and CEO, and the Compensation Committee has approved inducement awards for him [1] - Mr. Bancroft will receive a non-qualified stock option to purchase 59,034 shares of AEON Class A common stock and 177,103 restricted stock units (RSUs) under the 2025 Employment Inducement Incentive Award Plan [2][3] - The stock option and RSUs will vest over four years, with 25% vesting on each annual anniversary of the vesting commencement date [3] Group 2 - AEON Biopharma is focused on developing its proprietary botulinum toxin complex, ABP-450, for various therapeutic indications, initially targeting the neurosciences market [4] - ABP-450 is the same botulinum toxin complex marketed for cosmetic use by Evolus under the name Jeuveau and is manufactured in compliance with cGMP [4] - The company holds exclusive development and distribution rights for therapeutic indications of ABP-450 in the U.S., Canada, EU, UK, and other territories [4]

Earnings Release - Sempra plans to release its first-quarter 2025 earnings by 8 a.m. ET on Thursday, May 8 [1] - An accompanying slide presentation detailing the earnings results will be published to the Investors site by 8 a.m. ET on the same day [3] Conference Call - Jeffrey W. Martin, chairman and CEO, along with other senior leaders, will host a conference call at 12 p.m. ET on Thursday, May 8 [2] - Investors, media, analysts, and the public can listen to a live webcast of the conference call by registering on Sempra's Investors site [2] Company Overview - Sempra is a leading North American energy infrastructure company serving nearly 40 million consumers [4] - The company owns one of the largest energy networks in North America and is focused on electrifying and improving energy resilience in significant markets such as California, Texas, and Mexico [4] - Sempra is recognized for its sustainable business practices and operational excellence, as evidenced by its inclusion in the Dow Jones Sustainability Index North America [4]

MCLEAN, Va., April 21, 2025 /PRNewswire/ -- Appian (Nasdaq: APPN) today announced the appointment of Serge Tanjga to the position of Chief Financial Officer, effective as of May 27, 2025. He will report directly to Matt Calkins, CEO of Appian.Tanjga brings more than 20 years of financial experience to Appian. He was the Senior Vice President of Finance at MongoDB where he led financial planning, strategic finance, business operations, and analytics; and most recently, served as MongoDB's interim CFO. Serge ...